Establishing (177)Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer

Clinical (177)Lu-PSMA-617 radioligand therapy (RLT) is applied in advanced-stage prostate cancer. However, to the best of our knowledge murine models to study the biologic effects of various activity levels have not been established. The aim of this study was to optimize specific and total activity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Fendler, Wolfgang P., Stuparu, Andreea D., Evans-Axelsson, Susan, Lückerath, Katharina, Wei, Liu, Kim, Woosuk, Poddar, Soumya, Said, Jonathan, Radu, Caius G., Eiber, Matthias, Czernin, Johannes, Slavik, Roger, Herrmann, Ken
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2017
Assuntos:
Theranostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944167/
https://ncbi.nlm.nih.gov/pubmed/28546332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193359
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados